Abstract Background: The analysis of risk factors for predicting related complications has not been reported to date. Objective: This study aims to investigate the risk factors of related complications of percutaneous transluminal septal myocardial ablation (PTSMA) for hypertrophic obstructive cardiomyopathy (HOCM) retrospectively. Method: Clinical data, and one-year follow-up results of patients with HOCM, who underwent PTSMA between January 2000 and July 2013 in the Department of Cardiology, Liaoning Province People’s Hospital, Liaoning Province, China, were retrospectively analyzed to determine risk factors for operative complications with multiple logistic regression analysis. All p values are two-sided, with values of p < 0.05 being...
ObjectivesThis study sought to determine the long-term outcome of alcohol septal ablation (ASA).Back...
Background: Alcohol septal ablation (ASA) and septal myectomy (SM) are the standard therapeutic inte...
Hypertrophic cardiomyopathy (HCM) is a global disease of the myocardium with an incidence of 1:200 t...
Abstract Background: The analysis of risk factors for predicting related complications has not been...
Background: This study aims to evaluate early- and late outcomes of alcohol septal ablation (ASS) in...
Abstract Data on procedural complications and long term survival after alcohol septal ablation (ASA)...
Background-The impact of alcohol septal ablation (ASA)-induced scar is not known. This study sought ...
This study was conducted to assess outcomes after percutaneous transluminal septal myocardial ablati...
ObjectivesThis study analyzed changes in intracardiac conduction during transcoronary ablation of se...
ObjectivesWe sought to assess outcomes of alcohol septal ablation (ASA) in high-risk patients.Backgr...
BACKGROUND: Cardiac implantable electronic devices (CIED) are sometimes required after alcohol septa...
Background: Alcohol septal ablation (ASA) has been more commonly applied in medical refractory hyper...
Background—Septal reduction for obstructive hypertrophic cardiomyopathy may be performed by surgical...
Objectives: The purpose of the study is to identify the predictors of clinical outcome (mortality an...
Background. Hypertrophic cardiomyopathy is one of the most common types of cardiomyopathy. The appea...
ObjectivesThis study sought to determine the long-term outcome of alcohol septal ablation (ASA).Back...
Background: Alcohol septal ablation (ASA) and septal myectomy (SM) are the standard therapeutic inte...
Hypertrophic cardiomyopathy (HCM) is a global disease of the myocardium with an incidence of 1:200 t...
Abstract Background: The analysis of risk factors for predicting related complications has not been...
Background: This study aims to evaluate early- and late outcomes of alcohol septal ablation (ASS) in...
Abstract Data on procedural complications and long term survival after alcohol septal ablation (ASA)...
Background-The impact of alcohol septal ablation (ASA)-induced scar is not known. This study sought ...
This study was conducted to assess outcomes after percutaneous transluminal septal myocardial ablati...
ObjectivesThis study analyzed changes in intracardiac conduction during transcoronary ablation of se...
ObjectivesWe sought to assess outcomes of alcohol septal ablation (ASA) in high-risk patients.Backgr...
BACKGROUND: Cardiac implantable electronic devices (CIED) are sometimes required after alcohol septa...
Background: Alcohol septal ablation (ASA) has been more commonly applied in medical refractory hyper...
Background—Septal reduction for obstructive hypertrophic cardiomyopathy may be performed by surgical...
Objectives: The purpose of the study is to identify the predictors of clinical outcome (mortality an...
Background. Hypertrophic cardiomyopathy is one of the most common types of cardiomyopathy. The appea...
ObjectivesThis study sought to determine the long-term outcome of alcohol septal ablation (ASA).Back...
Background: Alcohol septal ablation (ASA) and septal myectomy (SM) are the standard therapeutic inte...
Hypertrophic cardiomyopathy (HCM) is a global disease of the myocardium with an incidence of 1:200 t...